| University of Alberta Patent applications |
| Patent application number | Title | Published |
|---|
| 20120016102 | NON-TOXIC BIOFILM INHIBITOR - The present invention relates to a composition, device and method for preventing or inhibiting biofilm formation on biotic or abiotic surfaces. The composition comprises a peptide based on the C-terminal receptor binding domain of | 01-19-2012 |
| 20100024078 | Diacylglycerol acyltransferases from flax - The invention relates to isolated diacylglycerol acyltransferases and polynucleotide sequences encoding the DGAT enzymes; polynucleotide constructs, vectors and host cells incorporating the polynucleotide sequences; and methods of producing and using same. Also provided are transformed cells and transgenic plants, with enhanced oil accumulation and quality. | 01-28-2010 |
| 20090249516 | Diacylglycerol acyltransferases from flax - The invention relates to isolated diacylglycerol acyltransferases and polynucleotide sequences encoding the DGAT enzymes; polynucleotide constructs, vectors and host cells incorporating the polynucleotide sequences; and methods of producing and using same. Also provided are transformed cells and transgenic plants, especially | 10-01-2009 |
| 20080307292 | Method and Apparatus for Digit-Serial Communications for Iterative Digital Processing Algorithms - An architecture and a method are provided for decoding codewords for codes such as low density parity check (LDPC) codes. An iterative decoding algorithm such as the Belief Propagation Algorithm (BPA) is employed that attempts to correct errors in an input block of symbols via a structure containing two sets of nodes through node processing and the passing of messages between nodes. Message passing and node processing is performed in a digit-serial manner instead of a bit-parallel manner. | 12-11-2008 |
| 20080287367 | Non-Toxic Biofilm Inhibitor - The present invention relates to a composition and method for preventing or inhibiting biofilm formation on biotic or abiotic surfaces. The composition comprises a peptide based on the C-terminal receptor binding domain of | 11-20-2008 |
